Patents Assigned to GalaGen Inc.
  • Publication number: 20020009429
    Abstract: The present invention provides compositions and methods for making and using antibodies. A pharmaceutical composition of the invention comprises a selected antigen and a Candida spp. antigen. Selected antigens include, for example, antigens derived from bacteria, yeasts, rickettsias, protozoas, viruses, parasites, and components or fragments thereof. Preferred compositions disclosed include antigens selected from Cryptosporidium spp. and Clostridium spp. The invention further provides for immunizing an animal with a composition of the invention to prepare a composition of immunoglobulins reactive with the selected antigen. The composition of immunoglobulins can be included in nutraceuticals that are ingested or administered enterally.
    Type: Application
    Filed: January 29, 1999
    Publication date: January 24, 2002
    Applicant: GalaGen, Inc.
    Inventor: EILEEN F. BOSTWICK
  • Patent number: 6051270
    Abstract: A liquid enteral tube feeding composition contains free amino acids and glutamine in a dipeptide form and prevents creaming out of fat from the composition.
    Type: Grant
    Filed: November 5, 1997
    Date of Patent: April 18, 2000
    Assignee: Galagen, Inc.
    Inventor: Woodrow C. Monte
  • Patent number: 5858378
    Abstract: The present invention provides a vaccine composition for enhancing the immune response of a mammal against a selected antigen. The vaccine composition of the invention comprises a combination of the selected antigen and a Candida spp. antigen. Selected antigens include, for example, a bacteria, yeast, rickettsia, protozoa, virus, parasite or components thereof. The composition may also contain adjuvants known in the art. A preferred vaccine composition for immunization against the selected antigen Cryptosporidium parvum is disclosed. The invention also provides a method for enhancing the immune response of a mammal against a selected antigen utilizing the vaccine compositions of the invention.
    Type: Grant
    Filed: May 2, 1996
    Date of Patent: January 12, 1999
    Assignee: Galagen, Inc.
    Inventor: Eileen F. Bostwick
  • Patent number: 5773000
    Abstract: The effective treatment of Clostridium difficile associated diseases, such as Clostridium difficile colitis, pseudomembranous colitis and antibiotic associated diarrhea, by administering an antibody having specific activity against Clostridium difficile colitis and toxins thereof alone or in combination with vancomycin, bacitracin or metronidazole is herein described as well as pharmaceutical compositions therefor.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: June 30, 1998
    Assignee: GalaGen Inc.
    Inventors: Eileen F. Bostwick, Robert A. Hoerr
  • Patent number: 5707678
    Abstract: Ultrafiltration of whey containing products at an acid pH reduces calcium levels in the concentrate and provides a concentrate that can be consistently microfiltered. The concentrate can be used, for example, in a method of microfiltering milk, milk serum, colostrum, or colostral serum which provides effective bioburden reduction without substantial loss of immunoglobulins.
    Type: Grant
    Filed: April 11, 1996
    Date of Patent: January 13, 1998
    Assignee: GalaGen Inc.
    Inventor: Antone G. Gregory
  • Patent number: 5670196
    Abstract: A method of microfiltering milk, milk serum, colostrum, or colostral serum which provides effective bioburden reduction without substantial loss of immunoglobulins.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: September 23, 1997
    Assignee: GalaGen Inc.
    Inventor: Antone G. Gregory